Leadless Versus Transvenous Single‐Chamber Ventricular Pacemakers: Real‐World Evidence From Aveir VR Coverage With Evidence Development Study

Background Aveir VR, a helix‐fixation leadless pacemaker (LP), was US Food and Drug Administration (FDA)‐approved in 2022. The performance of this novel LP has not been evaluated against transvenous single chamber ventricular pacemakers (TV‐VVI) in a real‐world setting. This observational coverage w...

Descrizione completa

Dettagli Bibliografici

Autori principali:	James E. Ip, Peter A. Brady, Anne M. Kroman, Blandine Mondésert, Leonard Ganz, Jennifer M. Joseph, Deepti Bettampadi, Yajing Hu, Yelena Nabutovsky, Rahul N. Doshi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-11-01
Serie:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:	Aveir leadless pacemakers outcomes reinterventions safety transvenous pacemakers
Accesso online:	https://www.ahajournals.org/doi/10.1161/JAHA.125.042471
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!